Biome Australia Director Increases Indirect Shareholding via On-Market Purchase

Biome Australia Ltd ( (AU:BIO) ) has issued an announcement.

Biome Australia Limited has disclosed a change in the indirect shareholding of director Geoffrey Sam, reflecting a routine update to his notifiable interest in the company. The notice shows that Sam, through family-related entities Burrangong Pty Ltd and Annandale Super Pty Ltd, increased his indirect stake via an on-market purchase of additional fully paid ordinary shares, signalling continued personal investment in the business.

Following the transaction, Sam’s indirect holdings rose by 80,000 shares in one of the family entities, taking that vehicle’s position to more than 6.15 million shares, while the other entity’s holding remained unchanged. Although modest in size, the on-market acquisition underscores the director’s ongoing financial alignment with shareholders and is likely to be viewed as a vote of confidence in Biome Australia’s prospects by market participants monitoring director dealings.

The most recent analyst rating on (AU:BIO) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.

More about Biome Australia Ltd

Biome Australia Limited operates in the health and wellness sector, focusing on nutraceuticals, probiotics, and related products designed to support gut health and broader wellbeing. The company targets consumers seeking clinically backed, science-based solutions and distributes its products through healthcare professionals, pharmacies, and retail channels within Australia and potentially selected international markets.

Average Trading Volume: 199,927

Technical Sentiment Signal: Sell

Current Market Cap: A$74.1M

For detailed information about BIO stock, go to TipRanks’ Stock Analysis page.